Andrea H Weinberger1, Jonathan M Platt2, Jonathan Shuter3, Renee D Goodwin4. 1. Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY 10461, USA; Department of Epidemiology & Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA. Electronic address: andrea.weinberger@einstein.yu.edu. 2. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA. Electronic address: JMP2198@cumc.columbia.edu. 3. AIDS Center and Division of Infectious Diseases, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY 10467, USA. Electronic address: JSHUTER@montefiore.org. 4. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA; Department of Psychology, Queens College and The Graduate Center, City University of New York (CUNY), 65-30 Kissena Boulevard, Queens, NY 11367, USA. Electronic address: renee.goodwin@qc.cuny.edu.
Abstract
BACKGROUND: Little is known about gender differences in withdrawal symptoms among smokers in the community. This study used longitudinal epidemiologic data to examine gender differences in current smokers' report of withdrawal symptoms during past quit attempts and the relationship between withdrawal symptoms and the odds of reducing or quitting smoking three years later. METHODS: Data were drawn from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC; Wave 1, 2001-2001, n=43,093; Wave 2, 2004-2005, n=34,653). Analyses were conducted on respondents who reported current daily cigarette smoking at Wave 1 (n=6911). Withdrawal symptoms during past quit attempts were assessed at Wave 1. Current smoking status was assessed at Wave 2. RESULTS: Wave 1 current smoking women, compared to men, were more likely to endorse any withdrawal symptoms, withdrawal-related discomfort, and withdrawal-related relapse (ps<0.0001). Women endorsed a greater number of withdrawal symptoms than men (M=2.37, SE=0.05 versus M=1.78, SE=0.04; p<0.0001). The odds of reducing and quitting smoking were significantly lower for respondents who reported any Wave 1 withdrawal symptoms, withdrawal-related discomfort, and withdrawal-related relapse. These relationships did not differ for women versus men. Among men, the odds of reducing smoking at Wave 2 decreased significantly with each cumulative withdrawal symptom compared to women (β interaction=0.87; p=0.01). CONCLUSIONS: Women were more likely to report withdrawal while the relationship between withdrawal symptoms and decreased likelihood of reducing smoking was stronger in men. Identifying gender differences in withdrawal can help develop strategies to help reduce withdrawal for both men and women.
BACKGROUND: Little is known about gender differences in withdrawal symptoms among smokers in the community. This study used longitudinal epidemiologic data to examine gender differences in current smokers' report of withdrawal symptoms during past quit attempts and the relationship between withdrawal symptoms and the odds of reducing or quitting smoking three years later. METHODS: Data were drawn from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC; Wave 1, 2001-2001, n=43,093; Wave 2, 2004-2005, n=34,653). Analyses were conducted on respondents who reported current daily cigarette smoking at Wave 1 (n=6911). Withdrawal symptoms during past quit attempts were assessed at Wave 1. Current smoking status was assessed at Wave 2. RESULTS:Wave 1 current smoking women, compared to men, were more likely to endorse any withdrawal symptoms, withdrawal-related discomfort, and withdrawal-related relapse (ps<0.0001). Women endorsed a greater number of withdrawal symptoms than men (M=2.37, SE=0.05 versus M=1.78, SE=0.04; p<0.0001). The odds of reducing and quitting smoking were significantly lower for respondents who reported any Wave 1 withdrawal symptoms, withdrawal-related discomfort, and withdrawal-related relapse. These relationships did not differ for women versus men. Among men, the odds of reducing smoking at Wave 2 decreased significantly with each cumulative withdrawal symptom compared to women (β interaction=0.87; p=0.01). CONCLUSIONS:Women were more likely to report withdrawal while the relationship between withdrawal symptoms and decreased likelihood of reducing smoking was stronger in men. Identifying gender differences in withdrawal can help develop strategies to help reduce withdrawal for both men and women.
Authors: Richard A Brown; Kathleen M Palm Reed; Erika Litvin Bloom; Haruka Minami; David R Strong; Carl W Lejuez; Christopher W Kahler; Michael J Zvolensky; Elizabeth V Gifford; Steven C Hayes Journal: Nicotine Tob Res Date: 2013-07-24 Impact factor: 4.244
Authors: Ovide F Pomerleau; Cynthia S Pomerleau; Ann M Mehringer; Sandy M Snedecor; Raphaela Ninowski; Ananda Sen Journal: Nicotine Tob Res Date: 2005-02 Impact factor: 4.244
Authors: Damaris J Rohsenow; Jennifer W Tidey; Christopher W Kahler; Rosemarie A Martin; Suzanne M Colby; Alan D Sirota Journal: Addict Behav Date: 2014-12-10 Impact factor: 3.913
Authors: Peter S Hendricks; J Lee Westmaas; Van M Ta Park; Christopher B Thorne; Sabrina B Wood; Majel R Baker; R Marsh Lawler; Monica Webb Hooper; Kevin L Delucchi; Sharon M Hall Journal: Psychol Addict Behav Date: 2013-03-25
Authors: Richard A Brown; C W Lejuez; David R Strong; Christopher W Kahler; Michael J Zvolensky; Linda L Carpenter; Raymond Niaura; Lawrence H Price Journal: Nicotine Tob Res Date: 2009-04-16 Impact factor: 4.244
Authors: Bridget F Grant; Deborah A Dawson; Frederick S Stinson; Patricia S Chou; Ward Kay; Roger Pickering Journal: Drug Alcohol Depend Date: 2003-07-20 Impact factor: 4.492
Authors: Benjamin A Toll; Peter Salovey; Stephanie S O'Malley; Carolyn M Mazure; Amy Latimer; Sherry A McKee Journal: Nicotine Tob Res Date: 2008-01 Impact factor: 4.244
Authors: Raina D Pang; Mariel S Bello; Madalyn M Liautaud; Andrea H Weinberger; Adam M Leventhal Journal: Nicotine Tob Res Date: 2019-07-17 Impact factor: 4.244
Authors: Joanna M Streck; Sarah H Heil; Stephen T Higgins; Janice Y Bunn; Stacey C Sigmon Journal: Exp Clin Psychopharmacol Date: 2018-02-01 Impact factor: 3.157